Biblio

Filters: Author is Sallam, Karim [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Cao X, Jahng JWS, Lee C, Zha Y, Wheeler MT, Sallam K, Wu JC. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations. Stem Cell Res. 2021;55:102455.

Jahng JWS, Black KE, Liu L, Bae HRyeong, Perez M, Ashley EA, Sallam K, Wu JC. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Res. 2021;53:102284.

Vera CD, Manhas A, Shenoy SP, Wheeler MT, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C. Stem Cell Res. 2022;63:102834.

Belbachir N, Lai C, Rhee J-W, Zhuge Y, Perez MV, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations. Stem Cell Res. 2021;57:102605.

Kojic A, Kim H, Guevara JV, Ravada S, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations. Stem Cell Res. 2022;64:102928.

Bonilauri B, Shin HSook, Htet M, Yan CD, Witteles RM, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation. Stem Cell Res. 2023;72:103215.

Garg P, Oikonomopoulos A, Chen H, Li Y, Lam CKeung, Sallam K, Perez M, Lux RL, Sanguinetti MC, Wu JC. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant. J Am Coll Cardiol. 2018;72(1):62-75.

M

Sallam K, Thomas D, Gaddam S, Lopez N, Beck A, Beach L, Rogers AJ, Zhang H, Chen IY, Ameen M, et al. Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA Sequencing. Circulation. 2022;145(17):1367-1369.

Rhee J-W, Yi H, Thomas D, Lam CKeung, Belbachir N, Tian L, Qin X, Malisa J, Lau E, Paik DT, et al. Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cell Rep. 2020;32(2):107886.

Wu H, Yang H, Rhee J-W, Zhang JZ, Lam CKeung, Sallam K, C Y Chang A, Ma N, Lee J, Zhang H, et al. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients. Eur Heart J. 2019.